HeyJaredInoculateTheWorld
Your premier source for mushroom intel, groundbreaking research, and cutting-edge stories from all across the psychedelic ecosystem. Home of the forthcoming Understory podcast.
- Indexed issues, last 90 days
- 9
- Latest publication
- Sep 28, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 3, 2026
Latest issues
On Psychedelic Narcissism (opens the original)
Read excerpt
Psychedelics have one dominant origin story in the popular imagination: they dissolve the ego. Aldous Huxley described his mescaline experience in The Doors of Perception as a kind of self-erasure, a state in which the boundary between himself and everything else went soft. Two decades of clinical research have mostly reinforced that story, tying ego dissolution to some of the strongest reported outcomes in psilocybin and MDMA trials for depression, addiction, and PTSD. But two threads of curren
The Mysterious Mushroom That Makes People See Tiny Marching Soldiers (opens the original)
Read excerpt
A man in Yunnan province sits down to a plate of stir-fried wild mushrooms. Ten or fifteen minutes later, something shifts. He lifts the tablecloth to check on something under the table and finds it crowded with tiny people, only a couple of centimeters tall, marching in formation like a miniature army. He isn’t drunk, isn’t sleep-deprived, and by every account isn’t lying. Subscribe nowAccording to hospital records reviewed by researchers at the University of Utah, 96
The Excommunication of John Allegro (opens the original)
Read excerpt
In April 1970, the London tabloid the Sunday Mirror began a four-part serial with a headline that read like a joke: a respected biblical scholar had concluded that Jesus Christ was never a man at all, but a mushroom. Readers who followed religious news more closely than tabloid gossip would have recognized the name attached to the claim. John Marco Allegro had spent the previous seventeen years building a public reputation as one of the most visible scholars working o
Meet The Far-Right Billionaires Funding The New Era of Psychedelic Medicine (opens the original)
Read excerpt
Psychedelics spent sixty years coded as countercultural, the province of Timothy Leary, Grateful Dead tour buses, and Bay Area therapists working just outside the law. The people now writing the biggest checks to bring them into the mainstream look nothing like that lineage. They’re Musk lieutenants fresh off a stint reorganizing the federal government, German financiers with a direct line to the Trump family, and a coalition of MAGA-aligned veterans’ advocates who describe ibogaine in the langu
The Rise and Fall (and Rebrand) of Psychedelic Stocks (opens the original)
Read excerpt
In September 2020, a British biotech company called Compass Pathways rang the opening bell at Nasdaq to list synthetic psilocybin as a publicly traded asset. It was the first of what became a small industry: within two years, companies built around MDMA, LSD-adjacent tryptamines, ketamine, ibogaine, and the toad-derived compound 5-MeO-DMT had all gone public, each pitching a version of the same story to investors, that the substances shamans, ravers, and underground therapists had been using for
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.